Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM- formulated human immunodeficiency virus type 1 vaccines in rhesus macaques: Evidence for viral clearance

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3292-3300

  Verschoor, Ernst J ^a   Mooij, Petra ^a   Oostermeijer, Herman ^a   Van Der Kolk, Mike ^a   Ten Haaft, Peter ^a   Verstrepen, Babs ^a   Sun, Yide ^b   Morein, Bror ^c   Åkerblom, Lennart ^c   Fuller, Deborah H ^d   Barnett, Susan W ^b   Heeney, Jonathan L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

^d PowderJect Vaccines Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; ISCOM; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; NEUTRALIZING ANTIBODY; NUCLEIC ACID;

ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RHESUS MONKEY; VACCINATION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS TITRATION;

EID: 0032978729     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3292-3300.1999     Document Type: Article

References (57)

1. Barnett, S. W., S. Rajasekar, H. Legg, B. Doe, D. H. Fuller, J. R. Haynes, C. M. Walker, and K. S. Steimer. 1997. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine 15:869-873.
2. Behboudi, S., B. Morein, and M. Villacres-Eriksson. 1997. In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations. Cytokine 9:682-687.
3. Bogers, W. M., H. Niphuis, P. ten Haaft, J. D. Laman, W. Koornstra, and J. L. Heeney. 1995. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 9:F13-F18.
4. Bogers, W. M. J. M., R. Dubbes, P. Ten Haaft, H. Niphuis, C. Cheng-Mayer, C. Stahl-Hennig, G. Hunsmann, T. Kuwala, M. Hayami, S. Jones, S. Ranjbar, N. Almond, J. Stott, B. Rosenwirth, and J. L. Heeney. 1997. Comparison of in vitro and in vivo infectivity of different clade B HIV-1 envelope chimeric simian/human immunodeficiency viruses in Macaca mulatta. Virology 236: 110-117.
5. Boyer, J. D., K. E. Ugen, B. Wang, M. Agadjanyan, L. Gilbert, M. L. Bagarazzi, M. Chattergoon, P. Frost, A. Javadian, W. V. Williams, Y. Refaeli, R. B. Ciccarelli, D. McCallus, L. Coney, and D. B. Weiner. 1997. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat. Med. 3:526-532.
6. Boyer, J. D., B. Wang, K. E. Ugen, M. Agadjanyan, A. Javadian, P. Frost, K. Dang, R. A. Carrano, R. Ciccarelli, L. Coney, W. V. Williams, and D. B. Weiner. 1996. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J. Med. Primatol. 25:242-250.
7. Bruck, C., C. Thiriart, L. Fabry, M. Francotte, P. Pala, O. Van Opstal, J. Culp, M. Rosenberg, M. De Wilde, P. Heidt, and J. L. Heeney. 1994. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12:1141-1148.
8. Burton, D. R., and J. P. Moore. 1998 Why do we not have an HIV vaccine and how can we make one? Nat. Med. 4:495-498.
9. Chapman, B. S., R. M. Thayer, K. A. Vincent, and N. L. Haigwood. 1991. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19:3979-3986.
10. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
11. Cheng-Mayer, C., T. Shioda, and J. A. Levy. 1991. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol. 65:6931-6941.
12. Doe, B., M. Selby, S. Barnett, J. Baenziger, and C. M. Walker. 1996. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93:8578-8583.
13. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158:2278-2284.
14. Francis, R. D., and H. B. Bradford, Jr. 1976. Some biological and physical properties of molluscum contagiosum virus propagated in cell culture. J. Virol. 19:382-388.
15. Fuller, D. H., M. Murphy-Corb, S. Barnett, K. Steimer, and J. R. Haynes. 1997. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine 15:924-926.
16. Fuller, D. H., and J. R. Haynes. 1994. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10:1433-1441.
17. Fuller, D. H., L. Simpson, K. S. Cole, J. E. Clements, D. L. Panicali, R. C. Montelaro, M. Murphey-Corb, and J. R. Haynes. 1997. Gene gun-based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIV. Immunol. Cell Biol. 75:389-396.
18. Haigwood, N. L., P. L. Nara, E. Brooks, G. A. Van Nest, G. Ott, K. W. Higgins, N. Dunlop, C. J. Scandella, J. W. Eichberg, and K. S. Steimer. 1992. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J. Virol. 66:172-182.
19. Heeney, J. L., C. Bruck, J. Goudsmit, L. Montagnier, A. Schultz, D. Tyrrell, and S. Zolla-Pazner. 1997. Immune correlates of protection to HIV infection and AIDS. Immunol. Today 18:4-8.
20. Heeney, J. L., P. Mooij, W. Bogers, D. Davis, B. Morein, C. de Giuli Morghen, T. Lehner, G. Voss, C. Bruck, C. Koopman, and B. Rosenwirth. 1998. Multiple immune effector mechanisms as correlates of HIV-1 vaccine protection, p. 281-285. In M. Girard and B. Dodet (ed.), Retroviruses of human AIDS and related animal diseases, Onzième ed. Elsevier, Paris, France.
21. Heeney, J. L., C. van Els, P. de Vries, P. ten Haaft, N. Otting, W. Koornstra, J. Boes, R. Dubbes, H. Niphuis, M. Dings, et al. 1994. Major histocompatibility complex class I-associated vaccine protection from simian immunode-ficiency virus-infected peripheral blood cells. J. Exp. Med. 180:769-774.
22. Heeney, J. L., M. E. van Gils, P. van der Meide, C. de Giuli Morghen, C. Ghioni, M. Gimelli, A. Raddelli, D. Davis, L. Åkerblom, and B. Morein. 1998. The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection. J. Med. Primatol. 27:50-58.
23. Heilman, C. A., and D. Baltimore. 1998. HIV vaccines - where are we going? Nat. Med. 4:532-534.
24. Herrmann, J. E., S. C. Chen, E. F. Fynan, J. C. Santoro, H. B. Greenberg, S. Wang, and H. L. Robinson. 1996. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 174:S93-S97.
25. Jassoy, C., and B. D. Walker. 1997. HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication. Springer Semin. Immunopathol. 18: 341-354.
26. Kuwata, T., T. Igarashi, E. Ido, M. Jin, A. Mizuno, J. Chen, and M. Hayami. 1995. Construction of human immunodeficiency virus 1/simian immunode-ficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J. Gen. Virol. 76:2181-2191.
27. + T helper cells that secrete IFN-γ and TNF-α. J. Immunol. 158:4471-4477.
28. Letvin, N. L., D. C. Montefiori, Y. Yasutomi, H. C. Perry, M. E. Davies, C. Lekutis, M. Alroy, D. C. Freed, C. I. Lord, L. K. Handt, M. A. Liu, and J. W. Shiver. 1997. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA 94:9378-9383.
29. Li, J., C. I. Lord, W. Haseltine, N. L. Letvin, and J. Sodroski. 1992. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 5:639-646.
30. Lu, S., J. Arthos, D. C. Montefiori, Y. Yasutomi, K. Manson, F. Mustafa, E. Johnson, J. C. Santoro, J. Wissink, J. I. Mullins, J. R. Haynes, N. L. Letvin, M. Wyand, and H. L. Robinson. 1996. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70:3978-3991.
31. Lu, Y., M. S. Salvato, C. D. Pauza, J. Li, J. Sodroski, K. Manson, M. Wyand, N. Letvin, S. Jenkins, N. Touzjian, C. Chutkowski, N. Kushner, M. LeFaile, L. G. Payne, and B. Roberts. 1996. Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:99-106.
32. Luciw, P. A., E. Pratt-Lowe, K. E. Shaw, J. A. Levy, and C. Cheng-Mayer. 1995. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc. Natl. Acad. Sci. USA 92:7490-7494.
33. McClements, W. L., M. E. Armstrong, R. D. Keys, and M. A. Liu. 1996. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B. alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA 93:11414-11420.
34. Mooij, P., M. Van der Kolk, W. M. J. M. Bogers, P. J. F. Ten Haaft, P. Van der Meide, N. Almond, J. Stott, M. Deschamps, D. Labbe, P. Momin, G. Voss, P. Von Hoegen, C. Bruck, and J. L. Heeney. 1998. A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection. AIDS 12:F1-F8.
35. Morein, B., K. Lövgren, B. Rönnberg, A. Sjölander, and M. Villacres-Eriksson. 1995. Immunostimulating complexes: clinical potential in vaccine development. Clin. Immunother. 3:461-475.
36. Morein, B., B. Sundquist, S. Höglund, K. Dalsgaard, and A. Osterhaus. 1984. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308:457-460.
37. Morein, B., M. Villacres-Eriksson, L. Ȧkerblom, B. Rönnberg, K. Lövgren, and A. Sjölander. 1994. Mechanisms behind the immune response induced by immunostimulating complexes. AIDS Res. Hum. Retroviruses 10:S109-S114.
38. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M. J. McElrath. 1997. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267-1274.
39. Pertmer, T. M., T. R. Roberts, and J. R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:6119-6125.
40. Prayaga, S. K., M. J. Ford, and J. R. Haynes. 1997. Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine 15:1349-1352.
41. Prince, A. M., R. Whalen, and B. Brotman. 1997 Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine 15:916-919.
42. Putkonen, P., E. Bjorling, L. Åkerblom, R. Thorstensson, K. Lövgren, L. Benthin, F. Chiodi, B. Morein, G. Biberfeld, and E. Norrby. 1994. Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine. J. Acquir. Immune Defic. Syndr. 7:551-559.
43. Raz, E., H. Tighe, Y. Sato, M. Corr, J. A. Dudler, M. Roman, S. L. Swain, H. L. Spiegelberg, and D. A. Carson. 1996. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA 93:5141-5145.
44. Robinson, H. L. 1997. Nucleic acid vaccines: an overview. Vaccine 15:785-787.
45. + T cell responses associated with control of viremia. Science 278:1447-1450.
46. Rowland-Jones, S., R. Tan, and A. McMichael. 1997. Role of cellular immunity in protection against HIV infection. Adv. Immunol. 65:277-346.
47. Singh, M., J. R. Carlson, M. Briones, M. Ugozzoli, J. Kazzaz, J. Barackman, G. Ott, and D. O'Hagan. 1998. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. Vaccine 16:1822-1827.
48. Sjölander, A., B. van't Land, and K. Lövgren Bengtsson. 1997. Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses. Cell. Immunol. 177:69-76.
49. Steimer, K. S., C. J. Scandella, P. V. Skiles, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science 254:105-108.
50. Ten Haaft, P. J. F., B. Verstrepen, K. Überla, B. Rosenwirth, and J. Heeney. 1998. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J. Virol. 72:10281-10285.
51. Traquina, P., M. Morandi, M. Contorni, and G. Van Nest. 1996. MF59 adjuvant enhances the antibody response to recombinant hepatitis B surface antigen vaccine in primates. J. Infect. Dis. 174:1168-1175.
52. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Feigner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
53. Valensi, J. P., J. R. Carlson, and G. A. Van Nest 1994. Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants. J. Immunol. 153:4029-4039.
54. van der Meide, P. H., R. J. Groenestein, M. C. de Labie, J. Heeney, P. Pala, and M. Slaoui. 1995. Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques. J. Med. Primatol. 24:271-281.
55. Villacres-Eriksson, M., S. Behboudi, A. J. Morgan, G. Trinchieri, and B. Morein. 1997. Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response. Cytokine 9:73-82.
56. Wang, B., J. Boyer, V. Srikantan, K. Ugen, L. Gilbert, C. Phan, K. Dang, M. Merva, M. G. Agadjanyan, M. Newman, et al. 1995. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation. Virology 211:102-112.
57. Yasutomi, Y., H. L. Robinson, S. Lu, F. Mustafa, C. Lekutis, J. Arthos, J. I. Mullins, G. Voss, K. Manson, M. Wyand, and N. L. Letvin. 1996. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol. 70:678-681.